safinamide

After an odyssey of setbacks, FDA finally green-lights Newron’s Parkinson’s drug Xadago
Endpoints
Wed, 03/22/17 - 11:11 am
FDA
Newron Pharma
Parkinson's Disease
Xadago
safinamide